Company / Assets per Share
Fulgent Genetics, Inc. Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$39.35
FY2025
5-year range
$39.35 / $45.96
FY2021-FY2025
Trend
-4.4%
vs FY2024
Sector context
#75 of 158
Health Care
What the data says
At $39.35, Fulgent Genetics, Inc.'s assets per share ranks #75 of 158 in the Health Care sector. Assets per Share has declined for 3 consecutive years, from $45.96 in FY2022 to $39.35 in FY2025.
Based on SEC 10-K filings.
39.35 in FY2025 with a 5-year CAGR of +3.8%.
Declined from $41.96 to $39.35 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -5.0%
- 5-Year CAGR
- +3.8%
- 10-Year CAGR
- -
Sector benchmark
#75 of 158 in Health CareTop 47% of 158This company $39.35 Sector average $116.83
▼
-66.3% below sector average
Key checks
Key Insights
- Fulgent Genetics, Inc.'s assets per share has declined for 3 consecutive years.
- In FY2025, assets per share decreased 4.4% year-over-year.
- Ranks #75 out of 158 companies in the Health Care sector.
- Peak assets per share was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 5.28 (safe zone, above 2.9 threshold)
- Negative profit margin: -15.1%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $39.35 | -4.4% |
| FY2024 | $41.14 | -2.0% |
| FY2023 | $41.96 | -8.7% |
| FY2022 | $45.96 | +1.3% |
| FY2021 | $45.38 | +39.2% |
| FY2020 | $32.61 | +567.6% |
| FY2019 | $4.88 | +61.7% |
| FY2018 | $3.02 | -6.6% |
| FY2017 | $3.24 | -1.5% |
| FY2016 | $3.28 | +566.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026